For my site visit, I presented an article that compared treatment options for BPH.

Here is a summary of the article:

This article is a Cochrane Review entitled “Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.” It was published in 2020, so it is based on research that is relevant and up to date. This review compares the results of the standard of treatment transurethral resection of the prostate (TURP) procedure to the newer, less invasive prostatic arterial embolization (PAE) method for improving lower urinary tract symptoms. This review found six RCTs and two NRSs with short-term (up to 12 months) follow-up and one RCT with long-term follow-up (13 to 24 months). 

The comparison study determined that both procedures provide similar improvements in urologic symptoms and quality of life. Furthermore, PAE may increase the need for re-treatment but it also may reduce ejaculatory disorders. In the long term, both procedures appear to have similar outcomes in regard to patient quality of life. Because PAE is a relatively new treatment, more research is still needed. For now, the certainty of the evidence remains low.

Jung_et_al-2020-Cochrane_Database_of_Systematic_Reviews-1